HomePSTV • NASDAQ
add
Plus Therapeutics Inc
Previous close
$0.32
Day range
$0.31 - $0.34
Year range
$0.24 - $2.55
Market cap
10.58M USD
Avg Volume
9.02M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.06M | -36.85% |
Operating expense | 4.60M | 107.64% |
Net income | -17.40M | -433.61% |
Net profit margin | -1.64K | -745.02% |
Earnings per share | -0.57 | 24.41% |
EBITDA | -3.39M | -7.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.87M | 206.05% |
Total assets | 12.06M | 114.48% |
Total liabilities | 35.70M | 241.34% |
Total equity | -23.64M | — |
Shares outstanding | 32.72M | — |
Price to book | -0.23 | — |
Return on assets | -94.60% | — |
Return on capital | 60.58% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -17.40M | -433.61% |
Cash from operations | -6.17M | -36.76% |
Cash from investing | 3.56M | 1,077.47% |
Cash from financing | 12.40M | 1,698.58% |
Net change in cash | 9.79M | 273.20% |
Free cash flow | -5.46M | -276.03% |
About
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. The company is headquartered in Houston, Texas, United States. Wikipedia
Founded
1996
Headquarters
Website
Employees
21
